EHA2024 vs EHA Guidelines Utilisation & Stats

EHA2024

Welcome to the EHA2024 Congress Mobile. The European Hematology Association promotes excellence in patient care, research, and education in hematology. EHA serves medical professionals, researchers, and scientists with an active interest in hematology and is proud to be the largest European-based organization connecting hematologists worldwide to support career development and research, harmonize hematology education, and advocate for hematologists and hematology. “Towards prevention, cure, and quality of life for all patients with blood disorders”. The EHA2024 Congress is taking place in-person from June 13-16, 2024 in Madrid and live-streamed. By downloading the Congress Mobile App, you have the Congress in the palm of your hands: browse the program, save sessions of your interest, find your location, access all content, and interact via the Q&A feature. For virtual attendees, the Congress Mobile App is the tool to follow the EHA Congress content from any device. For more information, check https://ehaweb.org/congress/eha2024-hybrid-congress/eha2024-hybrid-congress/

Apple App Store
Gratuit
Médical

Classement dans le store

- -

EHA Guidelines

The EHA Guidelines app is a free service offered by the European Hematology Association. The app contains hematology clinical practice guidelines, interactive tools, diagnostic algorithms, calculators, and more. The initial release features four pilot guidelines with full implementation of tools and interactivity, along with more guideline PDFs. Interactive versions of these guidelines are coming soon. App features: - Interactive guidelines for easy navigation - Full-text guidelines or direct link to guidelines - Interactive algorithms and tools - Add notes and bookmark important pages - Print or share important content or interactive pages For more information please contact us at guidelinesapp@ehaweb.org Note: These guidelines reflect the current state of scientific research and have been compiled with careful consideration of evidence-based criteria. Doctors are advised to fully incorporate these guidelines into their clinical judgment. However, the editor, authors, and software developer cannot guarantee the completeness, accuracy, correctness, and timeliness of the contents. Each user is requested to check the information provided in this app in each individual case and to act on their own responsibility. Any diagnosis, therapy, dosage, or application is at the user’s own risk.